STEVEN VAYALUMKAL: Open Payments
NPI 1700375391 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 4 companies in 2025. Trend: 2023 $218 · 2024 $295 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: ARISTADA, INGREZZA, REXULTI, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
